TMCI
Treace Medical Concepts Inc
4.50$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 77.9% | 78.7% | 77.2% | 75.9% | 74.0% | 74.3% | 72.6% | 71.5% | 70.2% | 69.3% | 67.1% | 66.5% | |
| 3.0% | 5.2% | 3.8% | 8.0% | 5.7% | 5.2% | 6.5% | 3.9% | 3.9% | 5.6% | 5.2% | 7.0% | |
| 50.8% | 48.9% | 45.3% | 42.0% | 38.9% | 34.9% | 37.0% | 33.6% | 29.2% | 25.4% | 28.2% | 25.2% | |
| 10.4% | 15.1% | 12.4% | 11.3% | 11.4% | 18.8% | 15.1% | 14.7% | 16.8% | 22.1% | 16.5% | 16.0% | |
| 12.2% | 11.6% | 14.8% | 18.3% | 20.5% | 18.1% | 18.4% | 20.5% | 21.1% | 18.9% | 19.8% | 21.8% | |
| 5.3% | 5.1% | 5.3% | 5.7% | 6.0% | 5.9% | 6.2% | 6.2% | 6.5% | 6.7% | 7.0% | 7.1% | |
| 3.9% | 3.6% | 3.6% | 3.8% | 3.9% | 3.7% | 3.8% | 3.7% | 3.7% | 3.7% | 3.7% | 3.7% | |
| 42.6% | 45.2% | 47.9% | 50.4% | 50.7% | 48.0% | 48.8% | 52.7% | 54.6% | 54.2% | 58.1% | 62.6% | |
| 13.8% | 17.9% | 19.4% | 19.7% | 18.0% | 16.1% | 16.1% | 20.3% | 20.8% | 16.1% | 18.7% | 22.9% | |
| 0.5% | 0.6% | 0.4% | 0.2% | 0.2% | 0.2% | 1.0% | 1.6% | 2.0% | – | – | 2.0% | |
| 3.6% | 4.7% | 8.7% | 8.0% | 8.8% | 4.8% | 6.4% | 9.7% | 8.2% | 3.5% | 7.4% | 8.9% | |
| 22.0% | 21.0% | 21.9% | 23.5% | 25.0% | 24.6% | 25.9% | 25.9% | 27.2% | 29.2% | 30.3% | 31.0% | |
| 57.4% | 54.8% | 52.1% | 49.6% | 49.3% | 52.0% | 51.2% | 47.3% | 45.4% | 45.8% | 41.9% | 37.4% | |
| -53.2% | -53.3% | -63.0% | -77.0% | -89.0% | -87.5% | -100.0% | -108.2% | -121.9% | -130.6% | -145.0% | -156.2% | |
| 25.6% | 24.5% | 25.5% | 27.5% | 29.2% | 28.7% | 30.4% | 30.5% | 32.3% | 33.5% | 35.1% | 35.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.